Publications by authors named "Katsuya Fujimori"

Article Synopsis
  • Subacute cough is a specific type of cough lasting 3-8 weeks and is primarily caused by cough variant asthma, atopic cough, and sinobronchial syndrome, rather than post-infectious cough as previously believed.
  • In a study involving 148 patients, 68.3% developed chronic cough, often stemming from multiple underlying conditions such as cough variant asthma combined with atopic cough.
  • The findings highlight the need for careful diagnosis and treatment of multiple causes in patients with subacute cough to prevent progression to chronic cough.
View Article and Find Full Text PDF
Article Synopsis
  • Chronic cough is a prevalent symptom in respiratory diseases that significantly impacts patients' lives and social interactions, highlighting the need for comprehensive studies in Japan.
  • The study involved 379 patients with a cough lasting over 8 weeks, ultimately analyzing 334 cases, revealing major causes like cough variant asthma and sinobronchial syndrome.
  • Findings indicate that patients with gastroesophageal reflux-associated cough had a lower treatment success rate and that undiagnosed cases took longer to treat, marking this as Japan's first nationwide investigation into chronic cough causes and treatments.
View Article and Find Full Text PDF
Article Synopsis
  • - The study explores how prebiotics, specifically 1-kestose, impact the intestinal microbiota and muscle health in elderly patients suffering from sarcopenia, a condition leading to reduced muscle mass and functionality.
  • - Results showed that after 12 weeks of 1-kestose administration, there was a significant increase in beneficial gut bacteria and improvements in body composition, including a higher skeletal muscle mass index and lower body fat percentage in the patients.
  • - This research is notable as it is the first to demonstrate that prebiotic supplementation can positively alter gut microbiota composition and support recovery from muscle atrophy in very elderly individuals with sarcopenia.
View Article and Find Full Text PDF

Background: The effect of inhaled corticosteroid (ICS) on the bone status of asthmatic patients is still uncertain, because it can differ by race and because there have been few cases in Japan. In this study, the bone status of ICS users with asthma was evaluated in an actual clinical setting in Japan.

Methods: In 7 participating hospitals, ICS users with asthma and control subjects were age- and gender-matched and recruited into this study.

View Article and Find Full Text PDF

Information on obstructive sleep apnea-hypopnea syndrome (OSAHS) in Japan has been limited. The purposes of this clinical study were to evaluate the demographic characteristics of Japanese OSAHS patients and to assess how demographic factors are associated with OSAHS severity. We analyzed 3,659 OSAHS patients who underwent polysomnographic evaluation between January 2000 and December 2004 at 11 hospitals in Niigata Prefecture, Japan.

View Article and Find Full Text PDF

Background And Objectives: Because inhaled corticosteroids (ICS) play a central role in the management of asthma, new drug delivery systems for fluticasone propionate, Diskhaler (FPdh) and Diskus (FPdk), were developed. However, few studies have focused on compliance with these drug delivery systems, which can influence drug efficacy. Hence, we compared compliance with FPdk versus that with FPdh.

View Article and Find Full Text PDF

A 75-year-old man who complained of progressive dyspnea was admitted to our hospital. He had been treated with rebamipide at an outpatient clinic for the preceding seven months. Atrial blood gas values obtained on admission indicated hypoxemia.

View Article and Find Full Text PDF